Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
15.96
+0.03 (0.19%)
Feb 4, 2026, 3:04 PM CST
SHE:300519 Revenue
Zhejiang Xinguang Pharmaceutical had revenue of 64.68M CNY in the quarter ending September 30, 2025, a decrease of -7.61%. This brings the company's revenue in the last twelve months to 257.07M, down -4.97% year-over-year. In the year 2024, Zhejiang Xinguang Pharmaceutical had annual revenue of 267.66M, down -1.01%.
Revenue (ttm)
257.07M
Revenue Growth
-4.97%
P/S Ratio
9.93
Revenue / Employee
813.50K
Employees
316
Market Cap
2.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 267.66M | -2.74M | -1.01% |
| Dec 31, 2023 | 270.40M | -81.09M | -23.07% |
| Jan 1, 2023 | 351.49M | 30.61M | 9.54% |
| Jan 1, 2022 | 320.88M | 37.80M | 13.35% |
| Dec 31, 2020 | 283.08M | -8.18M | -2.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Ginwa Enterprise (Group) | 550.44M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |